Cite
HARVARD Citation
Booijink, R. et al. (2022). A type IV Autotaxin inhibitor ameliorates acute liver injury and nonalcoholic steatohepatitis. EMBO molecular medicine. 14 (9), p. n/a. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Booijink, R. et al. (2022). A type IV Autotaxin inhibitor ameliorates acute liver injury and nonalcoholic steatohepatitis. EMBO molecular medicine. 14 (9), p. n/a. [Online].